Medifast, Inc.
MED
$12.72
-$0.40-3.05%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -109.28% | -86.73% | -95.13% | -126.93% | -79.19% |
| Total Depreciation and Amortization | 0.58% | 269.07% | -275.73% | -8.94% | 9.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 247.46% | -227.29% | 590.73% | 347.38% | -72.36% |
| Change in Net Operating Assets | 65.09% | 47.42% | -80.34% | -118.85% | -127.60% |
| Cash from Operations | -53.23% | -147.02% | -69.69% | -69.71% | -88.63% |
| Capital Expenditure | 17.33% | -141.54% | 17.16% | -11.12% | 12.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 43.04% | -75.23% | 99.12% | -- | -- |
| Cash from Investing | 25.98% | -81.07% | 96.16% | -45.18% | -31.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -65.71% |
| Repurchase of Common Stock | 54.83% | 90.00% | 98.18% | -700.00% | 88.05% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 72.68% | 100.00% | 99.99% | 99.98% | 96.29% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 62.24% | 99.99% | 99.98% | 99.89% | 94.24% |
| Foreign Exchange rate Adjustments | -- | 100.00% | -84.62% | -68.89% | 66.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.97% | -33.14% | 121.04% | -55.43% | -91.59% |